What Is Hostile Take-over
what is hostile take-over
Roche Announces $5.7 Billion Hostile Takeover Bid for Illumina | GenomeWeb Daily News | Sequencing
Saladax Biomedical said today that President and CEO Edward Erickson has resigned due to personal and family reasons, and that he will be replaced by Kevin Harter on an interim basis. Erickson will remain a member of the company's board of directors. Harter is a co-founder and senior VP of the Life Sciences Greenhouse, and he has served as executive chairman at Saladax.
Hostile Takeover: How Big Money and Corruption Conquered Our Government--And How We Take It BackLearn more
David Sirota
Helicos Biosciences has elected Bruce Ginsberg to its board of directors to review certain financing matters. Ginsberg is president and CEO of MooBella, a food service provider, and a member of the board of directors of Mac-Gray.
Hostile Takeover: How Big Business Bought Our Government and How We Can Take It BackLearn more
David Sirota
Life Technologies VP of Research and Development Manohar Furtado has been appointed to serve as an advisor on the National Biodefense Science Board, a federal advisory committee for the Department of Health and Human Services. The board provides advice on bioterrorism and other public health emergencies. Furtado was appointed to serve a four-year term on the board. Kevin Jarrell, CEO of Modular Genetics, also will continue to serve on the board.
0 コメント:
コメントを投稿